Accelerating Access to Individual Participant-Level Data via the Vivli Platform
- Funded by Wellcome Trust
- Total publications:0 publications
Grant number: 222346/Z/21/Z
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$1,403,852.72Funder
Wellcome TrustPrincipal Investigator
Dr. Rebecca LiResearch Location
United States of AmericaLead Research Institution
Vivli (Centre for Global Clinical Research Data)Research Priority Alignment
N/A
Research Category
Health Systems Research
Research Subcategory
Health information systems
Special Interest Tags
Data Management and Data Sharing
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Data repositories (such as IDDO and Vivli) have played a significant role in making research data available for secondary use. However, access to data needs to be further enhanced for accelerated innovations on infectious diseases by addressing the friction in data contribution, discoverability, access, and reuse. There is a strong alignment between Vivli the Wellcome's visions of improving the discovery and accessibility of Individual Participant Data related to COVID-19 in the short term, and for other infectious diseases in the long term. With this grant we seek direct support for discoverability and accessibility of data related to COVID-19, and to directly support Vivli to become an effective node in the "FAIR Data Network". The grant will focus on the following primary objectives: Recognition and credit for data contributions, Accelerated access to Individual Participant Data (IPD) hosted by Vivli, Discoverability of IDDO studies via the Vivli platform, and Discoverability of IPD hosted by Vivli and its platform partners (including IDDO) based on rich metadata).